Monthly News BB Biotech http://www.bbbiotech.ch/ NAV BB Biotech Monthly News BB Biotech http://www.bbbiotech.ch/ http://www.bbbiotech.ch/fileadmin/img/rss.gif Monthly News November 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-november-2009/

- Incyte: Announcement of a major partnership with Novartis- BioXell: Support of the planned...

 Monthly News October 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-october-2009/

- Vertex announces impressive Telaprevir data at the AASLD Meeting- Actelion reports solid 9-months...

 Monthly News September 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-september-2009/

- BB BIOTECH: Initiation of 6th share buyback on September 16, 2009- Incyte: Positive Phase II...

 Monthly News August 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-august-2009/

 

Actelion receives Tracleer label extension and approval for new Ventavis formulation in the...

 Monthly News July 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-july-2009-1/

- Celgene: Clinical study for use of Revlimid as a first-line treatment of multiple myeloma stopped...

 Monthly News June 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-june-2009-1/

- ASCO meeting highlights- Arena: presentation of Lorcaserin data at ADA

 Monthly News May 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-may-2009-1/

- Roche: Important new treatment option approved in the US for patients with the most aggressive...

 Monthly News April 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-april-2009-1/

- Actelion reported strong revenues and earnings - important news from clinical development...

 Monthly News March 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-march-2009-1/

-Roche and Genentech reach a friendly agreement to combine the two organizations-Celgene expects...

 Presentation STAR Conference Milano as of March 25, 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/presentation-star-conference-milano-as-of-march-252009/ Monthly News February 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-february-2009/

- Genentech's special committee rejects Roche's tender offer- Actelion: Actelion 2008 Financial...

 Monthly News January 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-january-2009/

- Roche announces tender offer for Genentech shares- ZymoGenetics and Bristol-Myers Squibb enter...

 Corporate presentation February 2009 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/corporate-presentation-february-2009-1/ Monthly News December 2008 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-december-2008-1/

- Actelion: Zavesca receives positive opinion for treating Niemann-Pick type C disease- NicOx: The...